SCHEMBL8256176

SCHEMBL8256176

CC(C)OC1=CC=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17340426 0.79
SCHEMBL30798646 0.78
SCHEMBL15196654 0.77 LMNA (0.37)
SCHEMBL28105881 0.77
SCHEMBL28105335 0.77
SCHEMBL11598282 0.76
SCHEMBL446703 0.75
SCHEMBL7939033 0.74
SCHEMBL28650715 0.74
SCHEMBL18576246 0.74 HPGD (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114634491-B Polycyclic compound for inhibiting RNA helicase DHX33 成都开悦生命科技有限公司 2024-03-19 CN disclosed
CN-114634491-A Polycyclic compound for inhibiting RNA helicase DHX33 成都开悦生命科技有限公司 2022-06-17 CN disclosed
EP-1879910-B1 TRIPEPTIDES AS HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-11-09 EP disclosed
WO-2006122188-A2 TRIPEPTIDES AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-11-16 WO disclosed